Key result
Deep learning AI analysis of 12-lead ECGs effectively predicts clinically significant CAD on angiography.
Why the study?
Does a deep learning artificial intelligence model analyzing resting 12-lead ECGs accurately predict clinically significant coronary artery disease in patients presenting for coronary angiography?
Observational (n=16,476)
Does a deep learning artificial intelligence model analyzing resting 12-lead ECGs accurately predict clinically significant coronary artery disease in patients presenting for coronary angiography?
Effect estimate: AUC 92.4% (95% CI 89.7%-95.1%)
A deep learning AI algorithm can accurately predict the presence of clinically significant coronary artery disease from a standard resting 12-lead ECG, potentially aiding in non-invasive risk stratification.
May aid noninvasive CAD detection; leaves open prospective validation before clinical adoption.
BACKGROUND: The current gold standard for the diagnosis of coronary artery disease (CAD) is invasive angiography; however, it is an invasive procedure. Therefore, we developed an artificial intelligence model designed to predict significant CAD from a resting digital 12-lead electrocardiogram (ECG). OBJECTIVES: This retrospective study assessed the model's ability to predict clinically significant CAD in a patient population presenting for coronary angiography. METHODS: From 2019 to 2021, 16,476 patients had a resting 12-lead digital ECG recorded within 90 days prior to coronary angiography. The artificial intelligence model was developed using 10-fold cross-validation methodology. Clinically significant disease was defined as angiographic diameter stenosis ≥70% in the left anterior descending, left circumflex, or right coronary artery or ≥50% in the left main coronary artery. We then applied the model to an external validation set. RESULTS: In the cross-validation cohort, the prevalence of clinically significant CAD was 64.5%; the model achieved a positive predictive value of 91.7% (95% CI: 89.9%-93.4%), negative predictive value of 72.8% (95% CI: 69.6%-76.0%), and area under the curve of 91.4% (95% CI: 89.4%-94.4%) in predicting clinically significant CAD. In external validation, the prevalence of clinically significant CAD was 36.0%; the model achieved a positive predictive value of 82.5% (95% CI: 75.9%-89.2%), negative predictive value of 88.1% (95% CI: 84.0%-92.1%), and area under the curve of 92.4% (95% CI: 89.7%-95.1%) in predicting clinically significant CAD. CONCLUSIONS: This study demonstrated the clinical utility of a deep learning artificial intelligence algorithm to analyze a digital 12-lead ECG to predict the presence of clinically significant CAD as determined by coronary angiography.
No takes yet. Share an insight, caveat, or question.
Leasure et al. (2026) conducted an observational in Coronary Artery Disease (n=16,476). Artificial intelligence model analyzing resting digital 12-lead ECG vs. Invasive coronary angiography was evaluated on Clinically significant CAD (angiographic diameter stenosis ≥70% in LAD, LCx, or RCA or ≥50% in LMCA) (AUC 92.4%, 95% CI 89.7%-95.1%). An artificial intelligence model analyzing resting 12-lead ECGs predicted clinically significant coronary artery disease with an area under the curve of 92.4% (95% CI 89.7-95.1) in external validation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: